ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC

Joyce Liang, Sarah Waliany, Andrew Do, Jennifer L Peterson, Paige Roberts, Elizabeth A Kennedy, Emily S Venanzi, Justin F Gainor, Jessica J Lin

Open source

DOI
10.1093/oncolo/oyaf217
Published
2025-07-17
Container
The Oncologist
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf217,
  title = {ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC},
  author = {Joyce Liang and Sarah Waliany and Andrew Do and Jennifer L Peterson and Paige Roberts and Elizabeth A Kennedy and Emily S Venanzi and Justin F Gainor and Jessica J Lin},
  year = {2025},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyaf217},
  url = {https://doi.org/10.1093/oncolo/oyaf217}
}

RIS

TY  - JOUR
TI  - ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC
AU  - Joyce Liang
AU  - Sarah Waliany
AU  - Andrew Do
AU  - Jennifer L Peterson
AU  - Paige Roberts
AU  - Elizabeth A Kennedy
AU  - Emily S Venanzi
AU  - Justin F Gainor
AU  - Jessica J Lin
PY  - 2025
JO  - The Oncologist
DO  - 10.1093/oncolo/oyaf217
UR  - https://doi.org/10.1093/oncolo/oyaf217
ER  - 

APA

Liang, J., Waliany, S., Do, A., Peterson, J. L., Roberts, P., Kennedy, E. A., Venanzi, E. S., Gainor, J. F., & Lin, J. J. (2025). ENIGMA+: a national, decentralized, remote consent study for clinical data and biospecimen collection in patients with ALK-positive advanced NSCLC. The Oncologist. https://doi.org/10.1093/oncolo/oyaf217

Source records